CTOs on the Move

Keros Therapeutics

www.kerostx.com

 
Keros Therapeutics is dedicated to the discovery and development of novel therapeutics for neuromuscular diseases
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.kerostx.com
  • 99 Hayden Avenue
    Lexington, MA USA 02421
  • Phone: 617.314.6297

Executives

Name Title Contact Details

Funding

Keros Therapeutics raised $23M on 01/08/2019
Keros Therapeutics raised $56M on 03/04/2020

Similar Companies

Bayer Healthcare Pharmacuticals

Committed to developing novel diagnostics and therapeutics that address unmet medical needs, Berlex, Inc., a U.S. affiliate of Schering AG, Germany (NYSE:SHR), develops and markets diagnostic imaging agents, treatments in the areas of female healthcare

Genitope Corporation

Genitope Corporation is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenomeDx Biosciences

Delivering Genomic Tests that Impact Treatment Decisions GenomeDx develops and commercializes genomic tests for prostate and other urologic cancers that have a direct impact on treatment decision-making, improve patient outcomes and ultimately reduce healthcare costs.

Allakos

Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The Company`s lead antibody, lirentelimab (AK002), is being evaluated in a Phase 3 study in eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) and a Phase 2/3 study in eosinophilic esophagitis (EoE). Lirentelimab targets Siglec-8, an inhibitory receptor selectively expressed on human mast cells and eosinophils. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs. Lirentelimab has been tested in multiple clinical studies. In these studies, lirentelimab eliminated blood and tissue eosinophils, inhibited mast cells and improved disease symptoms in patients with EG and/or EoD, EoE, mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria and indolent systemic mastocytosis.

Biotech Medical

Biotech Medical is a Canton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.